I now have comprehensive information from multiple authoritative textbooks. Here is the full synthesis:
Frozen Shoulder (Adhesive Capsulitis)
Definition
Frozen shoulder syndrome (FSS), or adhesive capsulitis, is a condition characterized by limited range of motion of the glenohumeral joint (GHJ) with pain at the extremes of movement. It was first described by Putman in 1882 and later by Codman. The term "adhesive capsulitis" was coined by Neviaser to describe a contracted, thickened joint capsule drawn tightly around the humeral head with relative absence of synovial fluid and chronic inflammatory changes in the subsynovial layer.
- Firestein & Kelley's Textbook of Rheumatology, p. 899
- Campbell's Operative Orthopaedics 15th Ed (2026), p. 2839
Epidemiology
- Incidence approximately 2% in the general population
- Age range 40-70 years; peaks in women in their 40s and 50s
- ~70% of patients are women
- 20-30% develop adhesive capsulitis in the contralateral shoulder
- In diabetics, bilateral disease occurs in 50% of cases
- Rarely recurs in the same shoulder
- Campbell's Operative Orthopaedics, p. 2839
Etiology and Risk Factors
The exact cause is unknown. It is frequently associated with:
| Risk Factor | Notes |
|---|
| Diabetes mellitus | Insulin-dependent patients ~5x more likely; no association with HbA1c level |
| Female sex | Accounts for ~70% of cases |
| Age > 49 years | |
| Prolonged immobilization | Most significant precipitating factor |
| Thyroid disorders | Hypo- and hyperthyroidism |
| Cardiovascular disease / MI | Can occur after myocardial infarction |
| Stroke | |
| Cervical disc disease | |
| Trauma / surgery | Even minor surgery at a remote site (e.g., hand) can precipitate FSS |
| Autoimmune diseases | |
| Hyperlipidemia | Proposed risk factor - evidence still evolving |
| Apical lung tumor, TB | Rarer associations |
Classification (Lundberg): "Primary" (no identifiable inciting event) vs. "Secondary" (after precipitant trauma or surgery). Surgical post-op shoulder stiffness is a form of secondary FSS but behaves more like an arthrofibrosis.
- Campbell's Operative Orthopaedics, p. 2839-2840
- Firestein & Kelley's, p. 899
Pathophysiology
The underlying process involves:
- Diffuse inflammatory synovitis of the shoulder capsule and synovium
- Reactive capsular fibrosis - fibroblastic proliferation driven by cytokines (TGF-beta1, metalloproteinases 2 and 9)
- Adherence and contraction of the capsular surfaces - loss of the axillary pouch and reduced joint volume
- Neoangiogenesis and neo-innervation - increased nerve growth factor receptor expression may explain the severe pain
- Alarmin molecules (e.g., HMGB1) are elevated in frozen shoulder capsules and correlate with pain severity
The CB1 (cannabinoid receptor 1) pathway has also been implicated in the pathogenesis.
- Campbell's Operative Orthopaedics, p. 2839-2840
Clinical Stages
Three-Phase Model (Clinical)
| Phase | Name | Duration | Features |
|---|
| 1 | Painful / Freezing | Weeks to months | Severe pain, exacerbated by movement; arm held adducted and internally rotated; night pain |
| 2 | Adhesive / Stiffening (Frozen) | 4-12 months | Minimal pain; progressive stiffness; periscapular compensatory symptoms; loss of ADLs |
| 3 | Resolution / Thawing | 5-26 months | Pain eases; motion slowly returns; some patients improve dramatically |
Four-Stage Arthroscopic Staging (Neviaser/Campbell)
| Stage | Arthroscopic Appearance |
|---|
| 1 | Pre-adhesive: fibrinous inflammatory synovitis with early adhesion formation |
| 2 | Acute adhesive synovitis with synovial proliferation; early adhesions in inferior capsular fold |
| 3 | Maturation: less synovitis, more fibrosis; axillary fold obliterated |
| 4 | Chronic: fully mature adhesions |
| 5 | Thawing phase |
- Campbell's Operative Orthopaedics, p. 2840
- Firestein & Kelley's, p. 899
Clinical Features
- Pain: diffuse, dull ache around the shoulder, referred to upper arm, back, and neck; worst at night; inability to sleep on the affected side
- Stiffness: global limitation - internal and external rotation lost first, then flexion; typically can only internally rotate to sacrum, 50% loss of ER, and <90° abduction
- Nondominant arm usually affected
- Pathognomonic sign: loss of active external rotation (Bailey & Love)
- Both active AND passive movement restricted (distinguishes from rotator cuff pathology where passive ROM is preserved)
- On passive ER testing: a sense of mechanical restriction is appreciated
Diagnosis
Diagnosis is clinical - based on history and physical examination showing restricted active and passive range of motion not due to other causes. There are no universally accepted formal criteria.
Investigations:
-
X-ray: usually normal; excludes osteoarthritis, fracture, calcific tendinitis, missed dislocation
-
Ultrasound/MRI: not routinely needed; characteristic MRI findings exist but rarely change management - useful to rule out other conditions
-
Blood tests: CBC, ESR, serum chemistry, TFTs to screen for an underlying metabolic cause
-
Tc-99m bone scan: may show increased uptake; more useful to exclude occult lesions or metastasis in uncertain cases
-
Rosen's Emergency Medicine, p. 662
-
Harrison's Principles of Internal Medicine 22E, p. 3018
Differential Diagnosis
- Calcific tendinitis
- Rotator cuff tear / tendinosis
- Subacromial bursitis
- GH joint osteoarthritis
- Chronic posterior GHJ dislocation (similar ER limitation)
- Polymyalgia rheumatica (when both shoulders affected)
- Infection, fracture
- Cervical radiculopathy
Management
Conservative (First-Line)
| Treatment | Notes |
|---|
| NSAIDs | Symptom relief; first-line in ED |
| Intra-articular / subacromial corticosteroid injection | Most benefit in painful (freezing) phase; transient pain relief in ~2/3 patients |
| Physiotherapy / exercise | Gentle stretching and assisted range-of-motion exercises; passive and active movement encouraged throughout |
| Heat application | Adjunct modality |
| TENS | Adjunct modality |
| Patient education | Reassurance about self-limiting nature; essential given the slow resolution |
Hydrodilatation (distension injection): Slow forceful injection of contrast material (or 20-30 mL local anaesthetic ± steroid) into the joint lyses adhesions and stretches the capsule - improves shoulder motion and facilitates physiotherapy.
Surgical / Interventional (for refractory cases)
- Manipulation under anaesthesia (MUA): accelerates return to normal function; one study showed 78% return to work within 2.6 months post-MUA
- Arthroscopic capsular release: releases the tight capsule; produces good pain relief and motion improvement
- Reserved for patients who fail conservative treatment over a prolonged period
Prevention
-
Avoid prolonged immobilization after minor shoulder injury
-
Early mobilization after shoulder injuries, surgery, or MI
-
Identify at-risk patients (diabetics, post-cardiac surgery patients) proactively
-
Bailey and Love's Surgery, p. 552
-
Rosen's Emergency Medicine, p. 662
-
Firestein & Kelley's, p. 899
Prognosis
- Generally self-limiting - resolves spontaneously in most cases within 1-3 years
- Diabetic patients tend to have a prolonged course (often considerably longer than 2 years)
- Many patients are left with some residual limitation of shoulder motion even after resolution
- Rarely recurs in the same shoulder
- Harrison's, p. 3018; Bailey and Love's, p. 552
Recent Evidence (2024-2026)
Three relevant systematic reviews published recently:
-
Pharmacological interventions (2024) - A network meta-analysis (PMID:
38538951) in
Rheumatology (Oxford) evaluated pharmacological options for early-stage frozen shoulder.
-
End-range physiotherapy interventions (2024) - A systematic review and meta-analysis (PMID:
37559358) in
Disability & Rehabilitation examined end-range mobilization approaches for primary adhesive capsulitis.
-
Radiofrequency ablation (2024) - A systematic review (PMID:
38988077) assessed radiofrequency ablation as a pain management option for shoulder pain including frozen shoulder.
These do not fundamentally change the management approach described above, but the pharmacological network meta-analysis may refine the relative positioning of intra-articular steroid vs. other agents in the freezing phase.
Sources: Firestein & Kelley's Textbook of Rheumatology | Campbell's Operative Orthopaedics 15th Ed (2026) | Harrison's Principles of Internal Medicine 22E | Rosen's Emergency Medicine | Bailey and Love's Short Practice of Surgery 28th Ed